Rua Bioscience and PharmAla partner to supply MDMA in New Zealand | The Biotech Times

Rua Bioscience will distribute PharmAla's GMP-grade LaNeo MDMA to authorised New Zealand psychiatrists following Medsafe's September approval for.

Share this story

Surfaced by this Google Alert